TickerFacts.

Nautilus Biotechnology, Inc. (NAUT): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$50.70M
Year ended 2025-12-31
-$50.23M
Trailing 12 months to 2026-06-30
2020-12-31: -$14.00M2021-12-31: -$39.24M2022-12-31: -$45.81M2023-12-31: -$51.71M2024-12-31: -$59.15M2025-12-31: -$50.70M-$50.70M
2020-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$50.70Mn/m2026-02-26, From 2025-01-01
2024-12-31-$59.15Mn/m2026-02-26, From 2024-01-01
2023-12-31-$51.71Mn/m2025-02-27, From 2023-01-01
2022-12-31-$45.81Mn/m2024-02-28, From 2022-01-01
2021-12-31-$39.24Mn/m2023-02-23, From 2021-01-01
2020-12-31-$14.00Mn/a2022-02-24, From 2020-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Nautilus Biotechnology, Inc. (NAUT)2025-12-31-$50.70Mn/m
908 Devices Inc. (MASS)2025-12-31-$23.69Mn/m
Seer, Inc. (SEER)2025-12-31-$44.45Mn/m
EyePoint, Inc. (EYPT)2025-12-31-$240.11Mn/m
Quanterix Corp (QTRX)2025-12-31-$77.24Mn/m
Harvard Bioscience Inc (HBIO)2025-12-31$6.73M+367.3%
Cytek Biosciences, Inc. (CTKB)2025-12-31-$4.69Mn/m
Rapid Micro Biosystems, Inc. (RPID)2025-12-31-$31.06Mn/m
Bionano Genomics, Inc. (BNGO)2025-12-31-$16.34Mn/m

Compare NAUT, MASS, SEER, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗